Shigeki Shimizu

4.8k citations
108 papers · 3.5k indexed · 1 hit paper · h-index 29
    • Lung Cancer Treatments and Mutations 37
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 12
    • Occupational and environmental lung diseases 8
    • Medical Imaging and Pathology Studies 8
    • Lung Cancer Diagnosis and Treatment 8
  • Oncology top 2%
    • Lung Cancer Research Studies 13
    • Cancer Immunotherapy and Biomarkers 7
    • Cancer Genomics and Diagnostics 12
  • Immunology top 5%

Shigeki Shimizu

102 papers receiving 3.5k citations

Hit Papers

The nuclear deubiquitinase BAP1 is commonly inactivated b...5122011202620162021100200300400500

Peers

Shigeki Shimizu
Comparison fields: 5 of 108
  • Pulmonary and Respiratory Medicine 1.9k
  • Oncology 1.4k
  • Cancer Research 481
  • Immunology 457
  • Biotechnology 145
Replace Sarah B. Goldberg with:
Sarah B. Goldberg United States
Yasuo Saijo Japan
Faye M. Johnson United States
Shunichi Tsujitani Japan
Yasushi Ichikawa Japan
Teh‐Ying Chou Taiwan
Patricia Fetsch United States
Ichiro Kinoshita Japan
Andreas Karameris Greece
Fulvio Lonardo United States
Shigeki Shimizu relative to Sarah B. Goldberg United States Sarah B. Goldberg's profile →
Citations per field
00.5×1.5×
Sarah B. Goldberg · 1×
Citations per year

Countries citing papers authored by Shigeki Shimizu

Since Specialization
Citations

This map shows the geographic impact of Shigeki Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Shimizu more than expected).

Fields of papers citing papers by Shigeki Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeki Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Shimizu. The network helps show where Shigeki Shimizu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shigeki Shimizu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shigeki Shimizu Line = papers co-authored together Shigeki Shimizu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20241
4 20242
5 20231
6 20231
7 20222
8 20225
9 2020172
10 20190
11 201910
12 201711
13 201151
14 201010
15 2009127
16 2006193
17 200655
18 200633
19
Measurement of serum levels of ca 549 an experimental breast cancer marker by photon elite random access analyzer
19871
20
19821

About Shigeki Shimizu

Shigeki Shimizu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 108 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (37 papers), Lung Cancer Research Studies (13 papers), Cancer Genomics and Diagnostics (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Occupational and environmental lung diseases (8 papers), Medical Imaging and Pathology Studies (8 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.9k citations), Oncology (1.4k citations) and Cancer Research (481 citations). Shigeki Shimizu has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Tetsuya Mitsudomi, Marc Ladanyi, Valerie W. Rusch, Adam B. Olshen, Motoki Yano, Takashi Takahashi, Yoshitaka Fujii, Maureen F. Zakowski, Hidefumi Sasaki and Ryuzo Ueda. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026